Olha V. Buriak, Ievgenii V. Gladukh, Maryna V. Podgaina, Volodymyr V. Rudenko

Abstract

Marketing research of medicinal products of the Silicone group (ATC code - A03A X13) for the treatment of gastrointestinal tract diseases has been carried out. Based on the results of the analysis of the pharmaceutical market, a sufficient number of registered drugs have been determined, among which drugs of Ukrainian origin insignificantly dominate. It has been established that 100% of registered silicone drugs are represented in the wholesale market. Structural analysis of dosage forms has shown a significant dominance of silicones in the form of oral drops (33% among 5 dosage forms of silicones). Evaluation of the economic availability of silicones within each dosage form has made it possible to state that the lowest DDD cost of silicone drugs corresponded to the form of chewable tablets, the highest - to oral suspension.